BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24016462)

  • 21. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case-control study.
    López Ramos D; Gabriel R; Cantero Perona J; Moreno Otero R; Fernández Bermejo M; Maté Jiménez J
    Rev Esp Enferm Dig; 2001 May; 93(5):303-14. PubMed ID: 11488108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory bowel disease. An epidemiological and genetic study.
    Monsén U
    Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS Registry.
    Levine A; de Bie CI; Turner D; Cucchiara S; Sladek M; Murphy MS; Escher JC;
    Inflamm Bowel Dis; 2013 Feb; 19(2):370-7. PubMed ID: 22570259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study.
    Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv Å; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirström G; Sandstedt B
    Scand J Gastroenterol; 2012 Feb; 47(2):162-9. PubMed ID: 22229803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center.
    Szántó K; Nyári T; Bálint A; Bor R; Milassin Á; Rutka M; Fábián A; Szepes Z; Nagy F; Molnár T; Farkas K
    PLoS One; 2018; 13(7):e0200824. PubMed ID: 30059523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence and risk factors of extraintestinal manifestations in children with inflammatory bowel disease].
    Shan CY; Zhang QQ; Xiao Y; Wang XQ; Yu Y; Xu X; Xu CD
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):694-699. PubMed ID: 31530355
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
    Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
    J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
    Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
    Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of chronic inflammatory bowel disease in the Northern area of Huelva.
    Garrido A; Martínez MJ; Ortega JA; Lobato A; Rodríguez MJ; Guerrero FJ
    Rev Esp Enferm Dig; 2004 Oct; 96(10):687-91; 691-4. PubMed ID: 15537375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.
    Rector A; Lemey P; Laffut W; Keyaerts E; Struyf F; Wollants E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2001 Oct; 2(6):323-8. PubMed ID: 11607788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
    Vermeire S; Pierik M; Hlavaty T; Claessens G; van Schuerbeeck N; Joossens S; Ferrante M; Henckaerts L; Bueno de Mesquita M; Vlietinck R; Rutgeerts P
    Gastroenterology; 2005 Dec; 129(6):1845-53. PubMed ID: 16344053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined segregation and linkage analysis of inflammatory bowel disease in the IBD1 region using severity to characterise Crohn's disease and ulcerative colitis. On behalf of the GISC.
    Forabosco P; Collins A; Latiano A; Annese V; Clementi M; Andriulli A; Fortina P; Devoto M; Morton NE
    Eur J Hum Genet; 2000 Nov; 8(11):846-52. PubMed ID: 11093274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy.
    Castiglione F; Diaferia M; Morace F; Labianca O; Meucci C; Cuomo A; Panarese A; Romano M; Sorrentini I; D'Onofrio C; Caporaso N; Rispo A
    J Crohns Colitis; 2012 Apr; 6(3):324-9. PubMed ID: 22405169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.
    Banerjee R; Pal P; Hutfless S; Ganesh BG; Reddy DN
    Intest Res; 2019 Oct; 17(4):486-495. PubMed ID: 31370386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of the Montreal classification for inflammatory bowel diseases.
    Spekhorst LM; Visschedijk MC; Alberts R; Festen EA; van der Wouden EJ; Dijkstra G; Weersma RK;
    World J Gastroenterol; 2014 Nov; 20(41):15374-81. PubMed ID: 25386087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.